Back to search

Article

PLPP2 as a metabolic and immune marker for predicting survival and enhancing response to anti-PD1 therapy in pancreatic cancer

2024-02-14

Abstract excerpt

<h4>Objective: </h4> The aim of this study was to establish genetic markers based on metabolic, stromal, and immune factors by analyzing pancreatic cancer (PC) transcriptome datasets to predict prognosis and response to PD-1 therapy in patients with PC. Methods We used the pancreatic cancer data set from the TCGA database to identify metabolic-related genetic markers through statistical analysis of artificial int...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
905e3ce2-331e-511c-8d42-cc547f675733
DOI
10.21203/rs.3.rs-3952664/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PLPP2 as a metabolic and immune marker for predicting survival and enhancing response to anti-PD1 therapy in pancreatic cancerDOI 10.21203/rs.3.rs-3952664/v1
Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancerSemantic proximity
Metabolic reprogramming shapes the immune microenvironment in pancreatic adenocarcinoma: prognostic implications and therapeutic targetsSemantic proximity
Integrating metabolic profiling of pancreatic juice with transcriptomic analysis of pancreatic cancer tissue identifies distinct clinical subgroupsSemantic proximity
Metabolic Syndrome Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal Carcinoma. A Novel Link Between Metabolic Dysregulation and Pancreatic Ductal Carcinoma.Semantic proximity
Metabolic Reprogramming：Application of lipid metabolism related genes in the risk model of clinical prognosis of pancreatic cancerSemantic proximity
A metabolism-relevant signature as a predictor for prognosis and therapeutic response in pancreatic cancer.Semantic proximity
Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic predictionSemantic proximity
Identification of stromal microenvironment characteristics and key molecular mining in pancreatic cancerSemantic proximity
Molecular Pathway and Immune Profile Analysis of IPMN-Derived versus PanIN-Derived Pancreatic Ductal AdenocarcinomasSemantic proximity
Integrative transcriptomics and single-cell analysis uncover prostaglandin-linked communication in high-risk pancreatic cancerSemantic proximity
Molecular signatures of tumor progression in pancreatic adenocarcinoma identified by energy metabolism characteristicsSemantic proximity
A novel sphingolipid metabolism-related long noncoding RNA signature predicts the prognosis, immune landscape and therapeutic response in pancreatic adenocarcinomaSemantic proximity
Select a neighboring publication to make it the new centre.